The union for managers and professionals in public service
Home  >  News and media  >  News  >  FDA secures new pay deal for civil servants
Friday 02 June 2023

FDA secures new pay deal for civil servants

In response to the FDA’s planned ballot for industrial action, Minister for the Cabinet Office Jeremy Quin has today presented a new package intended to recognise the contribution made by civil servants and the pressures felt during 2022/23.

This package includes:

  • An addendum to the 2023/24 Pay Remit Guidance to enable employers to pay an additional fixed £1,500 non-consolidated payment to assist with the increased cost of living. This will be paid to all civil servants covered by the pay remit process, including those on the centralised fast stream and will be subject to pro-rata arrangements for part time staff.
  • A commitment that the introduction of capability-based pay for the SCS is a ministerial priority and that the Cabinet Office will undergo a period of work as a matter of priority. The minister has committed to intensive engagement with the FDA on this issue and agreed meet with us as part of his personal commitment to its implementation.
  • A commitment to make no changes to the Civil Service Compensation Scheme before 2025. Alongside a commitment to avoid compulsory redundancies across the civil service.  

You can read the full details of the proposed package on the gov.uk website.

FDA General Secretary Dave Penman has welcomed this new pay deal: “The threat of industrial action must always be a last resort and the FDA’s decision to ballot for national industrial action over pay for the first time in 40 years was not taken lightly. It was intended to send a clear message to the government that enough was enough as they had failed to demonstrate that they valued the civil service equally with the rest of the public sector.

“This new pay deal represents a clear demonstration that this message has now been heard. For the first time in many years, we have reached a tangible, positive outcome for the civil service which compares well with the rest of the public sector.
“That, in itself, is no mean feat and I want to recognise the role played by ministers and the leadership of the civil service in achieving it. I welcome their commitment to continue to engage with us on the outstanding issues around the Senior Civil Service. Ministers need to demonstrate across a number of fronts that they value and respect the civil service, pay is only one of these, but it is a vital one and that should be recognised.
“This is a successful outcome for the FDA and the civil service. The £1,500 payment is a significant amount of money and will make a real difference to many civil servants struggling with the cost-of-living.”
The FDA’s Executive Committee will be meeting next week, on Thursday 8 June, and will formally consider the package and the implications for the ballot for industrial action which is currently paused.
23rd Nov 2023
The FDA’s new report, ‘The state of pay in the civil service’, paints a stark picture, with unambiguous testimony from civil servants detailing widespread dissatisfaction with the pay system, which is having a devasting impact on morale.
8th Mar 2024
In 1958, the Council of Women Civil Servants dissolved itself, believing its objectives were met. Sixty years later, the FDA’s five surviving female presidents met to discuss the challenges still facing women in senior roles and to reflect on their time leading the union.
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA